SEC 13F Intelligence

Rtw Investments, LP / TARS

Rtw Investments, LP’s Tarsus Pharmaceuticals Inc Position

Does Rtw Investments, LP own Tarsus Pharmaceuticals Inc (TARS)? Yes3.35M shares worth $235M (+2.34% of its 13F portfolio) as of Q1 2026, up from 3.34M shares the prior filed quarter.

Position Value
$235M
Q1 2026
Shares
3.35M
% of Portfolio
+2.34%
Quarters Held
22
currently held

Position History TARS

Reported value by quarter
Q4 ’20: $99MQ4 ’20Q1 ’21: $79MQ2 ’21: $58MQ3 ’21: $43MQ3 ’21Q4 ’21: $45MQ1 ’22: $34MQ2 ’22: $29MQ2 ’22Q3 ’22: $35MQ4 ’22: $37MQ1 ’23: $32MQ1 ’23Q2 ’23: $46MQ3 ’23: $51MQ4 ’23: $64MQ4 ’23Q1 ’24: $119MQ2 ’24: $93MQ3 ’24: $112MQ3 ’24Q4 ’24: $179MQ1 ’25: $170MQ2 ’25: $126MQ2 ’25Q3 ’25: $189MQ4 ’25: $273MQ1 ’26: $235MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.35M$235M+2.34%
Q4 20253.34M$273M+2.74%
Q3 20253.18M$189M+2.33%
Q2 20253.11M$126M+1.80%
Q1 20253.32M$170M+2.61%
Q4 20243.24M$179M+2.71%
Q3 20243.41M$112M+1.62%
Q2 20243.41M$93M+1.44%
Q1 20243.27M$119M+1.76%
Q4 20233.15M$64M+1.00%
Q3 20232.88M$51M+1.08%
Q2 20232.55M$46M+0.88%
Q1 20232.55M$32M+0.67%
Q4 20222.55M$37M+0.76%
Q3 20222.02M$35M+0.80%
Q2 20222.01M$29M+0.76%
Q1 20222.01M$34M+0.70%
Q4 20212.01M$45M+0.66%
Q3 20212.01M$43M+0.65%
Q2 20212.01M$58M+0.88%
Q1 20212.46M$79M+1.23%
Q4 20202.46M$99M+1.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of TARS.